Atrium Therapeutics to present non-clinical data showing ATR 1072 reverses and improves properties of PRKAG2 syndrome during HCMS at AHA Scientific Sessions 2026 -. Company announcement - FT.com.
Atrium Therapeutics to present non-clinical data showing ATR 1072 reverses and improves properties of PRKAG2 syndrome during HCMS at AHA Scientific Sessions 2026 -. Company announcement - FT.com.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in